TV presenter Sarah Beeny, known for her property expertise, has recently undergone surgery to remove her ovaries and fallopian tubes. The 51-year-old underwent the procedure after testing positive for the PALB2 gene mutation, which raises the risk of breast cancer. Earlier this year, Sarah revealed her battle with breast cancer and her decision to have a double mastectomy. In a candid interview, she discussed the challenges her marriage faced during her cancer journey. However, she and her husband Graham Swift have decided to stay together for the sake of their teenage children.
The PALB2 gene mutation, discovered in 2006, increases the risk of breast cancer when mutated, similar to the BRCA1 and BRCA2 genes. Individuals with this mutation have a 30-60% chance of developing breast cancer and a 50% chance of passing it on to their children.
Sarah shared an update on her surgery with her Instagram followers, describing it as "not quite the walk in the park" she expected. She also discussed her relationship with her husband, revealing that they have faced difficulties but have chosen to work on their marriage.
In addition to her surgery, Sarah has undergone gene testing to determine her family's risk of developing cancer. She discovered that she tested positive for the PALB2 gene mutation, which solidified her decision to have a double mastectomy. Sarah has also encouraged her family members to get tested.
Despite her cancer journey, Sarah remains optimistic and open about her experiences. In her new book, she spoke candidly about her battle with cancer but emphasized that it is just one part of her life. She expressed gratitude for completing her treatment and acknowledged the importance of the NHS in her journey.
Breast cancer is one of the most common cancers worldwide, affecting over two million women each year. It is crucial for individuals to be aware of the symptoms and to undergo regular mammograms for early detection. Treatment options for breast cancer may include surgery, chemotherapy, radiotherapy, and hormone therapy.